BiotechTube
Home/NKILT Therapeutics/Raphaël G. Ognar, MSc, MBA
RG

Raphaël G. Ognar, MSc, MBA

President, CEO, Co-Founder

NKILT Therapeutics

Therapeutic Areas

Oncology

NKILT Therapeutics Pipeline

DrugIndicationPhase
CIR-NK cells (HLA-G target)Refractory leukemias and solid tumorsPre-clinical

Leadership Team at NKILT Therapeutics

HB
Henri Bayle, Ph.D.
CSO, CDO, Co-Founder
View full NKILT Therapeutics profile